Gastrointestinal cancer

Erosive GORD raises cancer risk

Success for second-line therapy in gastric cancers

Growing push for surgical volume standards

GI cancers on the rise in under-50s

Prolonged PPI use linked to GI cancer

[mc4wp_form id=”39″]